Charles River Laboratories launched The DART Board, a new EurekaBlog series spotlighting topics in developmental and reproductive toxicology, including the inaugural article Why Every Ovarian Follicle Count Matters.
Public source
Publisher name
Public post
We're excited to launch The DART Board, a new #EurekaBlog series spotlighting timely topics, emerging challenges, and expert perspectives in developmental and reproducti…
Company
Charles River Laboratories
Together, We Create Healthier Lives
- Industry
- Biotechnology Research
- Location
- Wilmington, US
- Company size
- 10,001+ employees
About Charles River Laboratories
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
See moreLatest activity
Latest activity from Charles River Laboratories
47 signals
Products & Services
Charles River Laboratories released a fully automated cartridge production suite for bacterial endotoxin testing to drive greater quality, efficiency, traceability, and scalability.
People
Charles River Laboratories welcomed interns like Nokutenda Chelsea Choto to gain hands-on experience while discovering the people, culture, and sense of community that make Charles River special.
People
Charles River Laboratories welcomed Esther to the team
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
PhenoVista Biosciences
PhenoVista Biosciences released a new Investigative Toxicology App Note that reviews common client requests for nonclinical and preclinical safety profiling of therapeutic candidates.
Research & Knowledge
Microbiologics
Microbiologics published a commentary in Regulatory Toxicology and Pharmacology by 24 authors from FDA, The National Institutes of Health, the 3Rs Centre Utrecht, the National Institute of Health Sciences in Japan, large pharma, consulting, industry and academia.
Research & Knowledge
ScitoVation
ScitoVation published a new issue of ScitoVation Insight exploring the FDA's approach to New Approach Methodologies (NAMs) and what sponsors need to know.
Research & Knowledge
CN Bio
CN Bio published a new technology guide exploring how liver microphysiological systems can help researchers generate human-relevant insight, improve translational relevance, and reduce uncertainty in modern toxicology workflows.
Research & Knowledge
BioIVT